Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
4.470
-0.190 (-4.08%)
At close: May 14, 2026, 4:00 PM EDT
4.467
-0.003 (-0.06%)
After-hours: May 14, 2026, 7:09 PM EDT
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $449.58 million as of May 14, 2026. Its market cap has increased by 545.65% in one year.
Market Cap
449.58M
Enterprise Value
385.75M
1-Year Change
545.65%
Ranking
Category
Stock Price
$4.47
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $449.58M, a decrease of -44.26%. That is a compound annual growth rate of -9.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 468.69M | 96.14% |
| Dec 31, 2025 | 238.95M | 147.03% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 506.26M |
| Ocugen | 501.00M |
| Upstream Bio | 495.77M |
| XOMA Royalty | 494.50M |
| Rigel Pharmaceuticals | 484.75M |
| Assembly Biosciences | 483.29M |
| Ovid Therapeutics | 482.77M |
| Neurogene | 482.37M |